Publications by authors named "Agatha Labrinidis"

Claim this Profile
A
Automated micro-CT morphometry of femoral biopsies from hip arthroplasties: adaptive local thresholding, volume of interest wrapping and removal of debris.
Deepti K Sharma, Agatha Labrinidis, Xiangyu Dong, Christopher Schultz, Lucian B Solomon

Bone· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Craniofacial Phenomics: Three-Dimensional Assessment of the Size and Shape of Cranial and Dentofacial Structures.
Mustafa Mian, Jenny Tan, Robin Yong, Ruth Williams, Agatha Labrinidis

Methods Mol Biol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Micro-CT-Based Bone Microarchitecture Analysis of the Murine Skull.
Jenny Tan, Agatha Labrinidis, Ruth Williams, Mustafa Mian, Peter J Anderson

Methods Mol Biol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Selenium and Iodine on Oxidative Stress in the First Trimester Human Placenta Explants.
Nahal Habibi, Agatha Labrinidis, Shalem Yiner-Lee Leemaqz, Tanja Jankovic-Karasoulos, Dylan McCullough

Nutrients· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal Lateral Row Anchor Positioning in Posterior-Superior Transosseous Equivalent Rotator Cuff Repair: A Micro-Computed Tomography Study.
Matthias A Zumstein, Sumit Raniga, Agatha Labrinidis, Kevin Eng, Gregory I Bain

Orthop J Sports Med· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticancer efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in osteolytic breast cancer murine models.
Vasilios Liapis, Irene Zinonos, Agatha Labrinidis, Shelley Hay, Vladimir Ponomarev

Cancer Med· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow lesions detected by specific combination of MRI sequences are associated with severity of osteochondral degeneration.
Dzenita Muratovic, Flavia Cicuttini, Anita Wluka, David Findlay, Yuanyuan Wang, Agatha Labrinidis

Arthritis Res Ther· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma.
Vasilios Liapis, Agatha Labrinidis, Irene Zinonos, Shelley Hay, Vladimir Ponomarev

Cancer Lett· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doxorubicin overcomes resistance to drozitumab by antagonizing Inhibitor of Apoptosis Proteins (IAPs).
Irene Zinonos, Agatha Labrinidis, Vasilios Liapis, Shelley Hay, Vasilios Panagopoulos

Anticancer Res· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer.
Irene Zinonos, Ke-Wang Luo, Agatha Labrinidis, Vasilios Liapis, Shelley Hay

Int J Oncol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RECK in osteosarcoma: a novel role in tumour vasculature and inhibition of tumorigenesis in an orthotopic model.
Jonathan C M Clark, Toru Akiyama, David M Thomas, Agatha Labrinidis, Andreas Evdokiou

Cancer· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo.
Irene Zinonos, Agatha Labrinidis, Michelle Lee, Vasilios Liapis, Shelley Hay

J Bone Miner Res· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zoledronic acid protects against osteosarcoma-induced bone destruction but lacks efficacy against pulmonary metastases in a syngeneic rat model.
Agatha Labrinidis, Shelley Hay, Vasilios Liapis, David M Findlay, Andreas Evdokiou

Int J Cancer· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer.
Irene Zinonos, Agatha Labrinidis, Michelle Lee, Vasilios Liapis, Shelley Hay

Mol Cancer Ther· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted disruption of the CXCL12/CXCR4 axis inhibits osteolysis in a murine model of myeloma-associated bone loss.
Peter Diamond, Agatha Labrinidis, Sally K Martin, Amanda N Farrugia, Stan Gronthos

J Bone Miner Res· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in a mouse model.
Agatha Labrinidis, Shelley Hay, Vasilios Liapis, Vladimir Ponomarev, David M Findlay

Clin Cancer Res· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myeloma.
Agatha Labrinidis, Peter Diamond, Sally Martin, Shelley Hay, Vasilios Liapis

Clin Cancer Res· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does Apo2L/TRAIL play any physiologic role in osteoclastogenesis?
Agatha Labrinidis, Vasilios Liapis, Le M Thai, Gerald J Atkins, Cristina Vincent

Blood· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL.
Lisa M Butler, Vasilios Liapis, Stelios Bouralexis, Katie Welldon, Shelley Hay, Agatha Labrinidis

Int J Cancer· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apo2l/Tumor necrosis factor-related apoptosis-inducing ligand prevents breast cancer-induced bone destruction in a mouse model.
Le Minh Thai, Agatha Labrinidis, Shelley Hay, Vasilios Liapis, Steve Bouralexis

Cancer Res· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis